Coming October 2: SITC releases abstract titles with each presenting author’s institution (nearly 1,300 last year). We’ll add them to this guide once they’re out.

Iovance Biotherapeutics at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Iovance Biotherapeutics exhibits at Booth 700 at SITC 2026 in Phoenix, and takes part in 3 sessions. Its program focuses on the regulatory framework for new immuno-oncology agents. The company makes cell therapies from tumor-infiltrating lymphocytes to treat solid tumors.

OrganizationSITC 2026 Attendance
iovance.com
Biotech
Develops and commercializes tumor-infiltrating lymphocyte (TIL) cell therapies for people with solid tumors.
Booth
Exhibiting at Booth 700
Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm
Session
Wed Nov 4
4:10pm–4:55pm
Workshop
Fri Nov 6
1:10pm–1:25pm
Workshop
Sat Nov 7
6:55pm–7:10pm

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Iovance Biotherapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction